Although marginally significant (p = 0.053) in the discovery cohort, SAA2 was selected due to its function as an indicator of special humoral immune responses in B-cell lymphoma induced by germinal center–associated lymphoma (HGAL) genes (49). The gene discussed is SAA2; the disease is B-cell non-Hodgkin lymphoma.